The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
Open accessAbstract
A dynamic estimation of the involvement of the complement system in various diseases was obtained by the direct quantitation of breakdown products of C3 and of properdin factor B. The methods used were based, first on the separation of native and fragmented molecules according to their molecular size through a precipitation with polyethylene glycol and, secondly, on an immunochemical quantitation, using specific antisera for the major antigens of C3 and factor B. The sensitivity and the specificity of these methods were demonstrated by activation of complement in vitro with generation of C3 and factor B fragments. A clinical investigation was carried out in 41 patients with systemic lupus erythematosus (SLE), 31 with membranoproliferative glomerulonephritis (MPGN), 26 with other types of glomerulonephritis, and 6 with severe alcoholic cirrhosis of the liver. The following observations were made: (a) an elevated plasma level of C3d fragment of C3 was found in 68% of SLE patients, in 87% of MPGN patients, in 62% of patients with other hypocomplementemic nephritis, and in 15% of those with normocomplementemic nephritis, but in only 33% of patients with liver cirrhosis and very low levels of C3; (b) a significant difference was observed between the levels of C3 obtained with either anti-"native" C3 or anti-C3c sera for immunochemical quantitation, in patients with SLE or MPGN, indicating the presence of "altered" or fragmented C3 in plasma; (c) an elevated plasma level of Ba fragment of properdin factor B was found in 46% of SLE patients, in 67% of MPGN patients, in 50% of patients with other hypocomplementemic nephritis, and in 9% of patients with normocomplementemic nephritis, while the level of properdin factor B was only slightly decreased in these diseases; (d) in SLE and MPGN there was an inverse correlation between the levels of C3d and Ba and the level of C3 in plasma. The level of these fragments was directly correlated with the clinical manifestations of SLE; (e) some patients with a normal C3 level exhibited an elevated plasma concentration of C3 and factor B fragments, suggesting the coexistence of an increased synthesis with a hypercatabolism of complement components. Therefore, the quantitation of complement breakdown products by simple immunochemical methods provides additional information concerning the involvement of complement in disease and new features for the evaluation of the intensity of immune reactions during immune complex diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pillemer, L., Blum, L., Lepow, I. H., Ross, O. A., Todd, E. W., & Wardlaw, A. C. (1954) · Science · doi:10.1126/science.120.3112.279 · Cited by 938
Creighton, W. D., Lambert, P. H., & Miescher, P. A. (1973) · The Journal of Immunology · doi:10.4049/jimmunol.111.4.1219 · Cited by 421
Self-citationNilsson, U. R., & Müller-Eberhard, H. J. (1965) · The Journal of Experimental Medicine · doi:10.1084/jem.122.2.277 · Cited by 412
Wold, R. T., Young, F. E., Tan, E. M., & Farr, R. S. (1968) · Science · doi:10.1126/science.161.3843.806 · Cited by 378
Studies of the In Vivo Behavior of Human C′3 in Normal Subjects and Patients*
Alper, C. A., & Rosen, F. S. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105691 · Cited by 226
CHARLESWORTH, J. A., Williams, D. G., Sherington, E., Lachmann, P. J., & Peters, D. K. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107708 · Cited by 154
Metabolism of Third Complement Component (C3) in Nephritis
Hunsicker, L. G., Ruddy, S., Carpenter, C. B., Schur, P. H., Merrill, J. P., Müller‐Eberhard, H. J., & Austen, K. F. (1972) · New England Journal of Medicine · doi:10.1056/nejm197210262871701 · Cited by 131
Sliwinski, A. J., & Zvaifler, N. J. (1972) · PubMed · Cited by 79
Anti-nuclear factors and serum complement in systemic lupus erythematosus.
Morse, J. H., Müller‐Eberhard, H. J., & Kunkel, H. G. (1962) · Europe PMC (PubMed Central) · Cited by 66
Perrin, L. H., Lambert, P., Nydegger, U. E., et al. (1973) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(73)90032-9 · Cited by 46
Self-citation
Cited by
The Biology and Detection of Immune Complexes
Theofilopoulos, A. N., & Dixon, F. J. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60800-7 · Cited by 467
Hacbarth, E., & Kajdacsy‐Balla, A. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291105 · Cited by 268
Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects
Michel, O., Duchateau, J., & Sergysels, R. (1989) · Journal of Applied Physiology · doi:10.1152/jappl.1989.66.3.1059 · Cited by 257
Links between complement abnormalities and systemic lupus erythematosus
Pickering, M. C., & Walport, M. J. (2000) · Rheumatology · doi:10.1093/rheumatology/39.2.133 · Cited by 168
Metadata
- Authors
- Perrin, L. H., Lambert, P. H., & Miescher, P. A.
- Venue
- Journal of Clinical Investigation
- Published
- 1975-07-01
- Volume
- 56
- Issue
- 1
- Pages
- 165-176
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2155897042
- Cited by
- 268
- References
- 10
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. https://app.cochat.ai/papers/10.1172/jci108065
- The paper
- Perrin, L. H., Lambert, P. H., & Miescher, P. A. (1975). Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. Journal of Clinical Investigation. https://doi.org/10.1172/jci108065
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.